Creso Pharma expands presence in Europe as it enters Portugal and Spain
Finfeed
Archived
Aug 12, 2020
Creso Pharma Limited (ASX: CPH; FRA: 1X8) has signed a commercial agreement with DHS Business Portugal to introduce the group’s products into the Portuguese and Spanish markets, effectively expanding the company’s presence in Europe.
